Genomtec S.A. (GMT) — Strategic Asset Allocation Index
Genomtec S.A. (GMT) has a Strategic Asset Allocation Index of 15.1% as of June 2023. Strategic assets (PP&E of zł2.00 Million plus long-term investments of zł-) total zł2.00 Million, measured against net assets of zł13.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check GMT asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Genomtec S.A. Strategic Asset Allocation Index (2020–2021)
This chart shows how Genomtec S.A.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 15.1%, representing strategic assets of zł2.00 Million against net assets of zł13.22 Million PLN. See financial agility of Genomtec S.A. to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Genomtec S.A. (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Genomtec S.A. from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Genomtec S.A. (GMT) market capitalisation.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 258.5% | zł1.91 Million | zł1.91 Million | zł- | zł738.00K | ▲ +242.2 pp |
| 2020 | 16.4% | zł1.24 Million | zł1.24 Million | zł- | zł7.57 Million | — |